Richard Johnson

In addition to his role with DFJ Mercury, Dr. Johnson recently founded Hudson Medical Communications (“Hudson”) a full service medical marketing company; MedIQ, a continuing medical education (CME) company; and Hudson BioScience, a late phase clinical research business.
In addition, he founded Performax (2004), a physical therapy, rehabilitation, and sports training clinic.
While all of these companies remain private, each of them is profitable and on track for a positive exit.
He is an accomplished life sciences executive who has held executive marketing, corporate development, and operating positions with numerous bio-pharmaceutical and health care services companies.
Previously, Dr. Johnson was the CEO of Quintiles Commercialization North America, a group of Quintiles subsidiaries which had combined revenues of over $300 million at the time of his departure.
As CEO, Dr. Johnson executed a highly successful turnaround, taking the company from a substantial loss in 2001 to record-setting profit margins within one year.
In his role, he was also involved in investments made by Quintiles’ corporate venture arm, PharmaBio Development.
Prior to becoming CEO of Quintiles Commercialization, Dr. Johnson was CEO of Quintiles Integrated Strategic Solutions and Quintiles Medical Communications.
Previously, he was a founder of Q.E.D.
Communications, a strategic medical communications firm which was acquired by Quintiles Transnational.
Dr. Johnson earned a bachelor’s degree (Phi Beta Kappa) from New York University and a medical degree from Mount Sinai School of Medicine.
In addition, he received graduate business training from Columbia University’s Executive Management Training Program.